Plasma-derived Therapies Market - Global Outlook and Forecast 2021-2027

Plasma-derived Therapies Market - Global Outlook and Forecast 2021-2027

Report Code: KNJ696001 | No. of Pages: 91 | Category: Technology
Publisher: Market Monitor Global | Date of Publish: Apr-2021 
This report contains market size and forecasts of Plasma-derived Therapies in Global, including the following market information:
Global Plasma-derived Therapies Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Plasma-derived Therapies market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Plasma-derived Therapies companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Plasma-derived Therapies Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Plasma-derived Therapies Market Segment Percentages, By Type, 2020 (%)
Albumin
Immunoglobulin
Factor VIII
Others

China Plasma-derived Therapies Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Plasma-derived Therapies Market Segment Percentages, By Application, 2020 (%)
Hemophilia
Primary Immunodeficiencies (PIDs)
Idiopathic Thrombocytopenic Purpura (ITP)
COVID-19
Others

Global Plasma-derived Therapies Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Plasma-derived Therapies Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Plasma-derived Therapies Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Plasma-derived Therapies Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
CSL Behring LLC
Shire
Bayer
Kedrion
Takeda
Biotest
Octaparma
Bio Products Laboratory (BPL)
LFB
Grifols
1 Introduction to Research & Analysis Reports
    1.1 Plasma-derived Therapies Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Plasma-derived Therapies Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Plasma-derived Therapies Overall Market Size
    2.1 Global Plasma-derived Therapies Market Size: 2021 VS 2027
    2.2 Global Plasma-derived Therapies Market Size, Prospects & Forecasts: 2016-2027
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Plasma-derived Therapies Players in Global Market
    3.2 Top Global Plasma-derived Therapies Companies Ranked by Revenue
    3.3 Global Plasma-derived Therapies Revenue by Companies
    3.4 Top 3 and Top 5 Plasma-derived Therapies Companies in Global Market, by Revenue in 2020
    3.5 Global Companies Plasma-derived Therapies Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Plasma-derived Therapies Players in Global Market
        3.6.1 List of Global Tier 1 Plasma-derived Therapies Companies
        3.6.2 List of Global Tier 2 and Tier 3 Plasma-derived Therapies Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Plasma-derived Therapies Market Size Markets, 2021 & 2027
        4.1.2 Albumin
        4.1.3 Immunoglobulin
        4.1.4 Factor VIII
        4.1.5 Others
    4.2 By Type - Global Plasma-derived Therapies Revenue & Forecasts
        4.2.1 By Type - Global Plasma-derived Therapies Revenue, 2016-2021
        4.2.2 By Type - Global Plasma-derived Therapies Revenue, 2022-2027
        4.2.3 By Type - Global Plasma-derived Therapies Revenue Market Share, 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Plasma-derived Therapies Market Size, 2021 & 2027
        5.1.2 Hemophilia
        5.1.3 Primary Immunodeficiencies (PIDs)
        5.1.4 Idiopathic Thrombocytopenic Purpura (ITP)
        5.1.5 COVID-19
        5.1.6 Others
    5.2 By Application - Global Plasma-derived Therapies Revenue & Forecasts
        5.2.1 By Application - Global Plasma-derived Therapies Revenue, 2016-2021
        5.2.2 By Application - Global Plasma-derived Therapies Revenue, 2022-2027
        5.2.3 By Application - Global Plasma-derived Therapies Revenue Market Share, 2016-2027
6 Sights by Region
    6.1 By Region - Global Plasma-derived Therapies Market Size, 2021 & 2027
    6.2 By Region - Global Plasma-derived Therapies Revenue & Forecasts
        6.2.1 By Region - Global Plasma-derived Therapies Revenue, 2016-2021
        6.2.2 By Region - Global Plasma-derived Therapies Revenue, 2022-2027
        6.2.3 By Region - Global Plasma-derived Therapies Revenue Market Share, 2016-2027
    6.3 North America
        6.3.1 By Country - North America Plasma-derived Therapies Revenue, 2016-2027
        6.3.2 US Plasma-derived Therapies Market Size, 2016-2027
        6.3.3 Canada Plasma-derived Therapies Market Size, 2016-2027
        6.3.4 Mexico Plasma-derived Therapies Market Size, 2016-2027
    6.4 Europe
        6.4.1 By Country - Europe Plasma-derived Therapies Revenue, 2016-2027
        6.4.2 Germany Plasma-derived Therapies Market Size, 2016-2027
        6.4.3 France Plasma-derived Therapies Market Size, 2016-2027
        6.4.4 U.K. Plasma-derived Therapies Market Size, 2016-2027
        6.4.5 Italy Plasma-derived Therapies Market Size, 2016-2027
        6.4.6 Russia Plasma-derived Therapies Market Size, 2016-2027
        6.4.7 Nordic Countries Plasma-derived Therapies Market Size, 2016-2027
        6.4.8 Benelux Plasma-derived Therapies Market Size, 2016-2027
    6.5 Asia
        6.5.1 By Region - Asia Plasma-derived Therapies Revenue, 2016-2027
        6.5.2 China Plasma-derived Therapies Market Size, 2016-2027
        6.5.3 Japan Plasma-derived Therapies Market Size, 2016-2027
        6.5.4 South Korea Plasma-derived Therapies Market Size, 2016-2027
        6.5.5 Southeast Asia Plasma-derived Therapies Market Size, 2016-2027
        6.5.6 India Plasma-derived Therapies Market Size, 2016-2027
    6.6 South America
        6.6.1 By Country - South America Plasma-derived Therapies Revenue, 2016-2027
        6.6.2 Brazil Plasma-derived Therapies Market Size, 2016-2027
        6.6.3 Argentina Plasma-derived Therapies Market Size, 2016-2027
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Plasma-derived Therapies Revenue, 2016-2027
        6.7.2 Turkey Plasma-derived Therapies Market Size, 2016-2027
        6.7.3 Israel Plasma-derived Therapies Market Size, 2016-2027
        6.7.4 Saudi Arabia Plasma-derived Therapies Market Size, 2016-2027
        6.7.5 UAE Plasma-derived Therapies Market Size, 2016-2027
7 Players Profiles
    7.1 CSL Behring LLC
        7.1.1 CSL Behring LLC Corporate Summary
        7.1.2 CSL Behring LLC Business Overview
        7.1.3 CSL Behring LLC Plasma-derived Therapies Major Product Offerings
        7.1.4 CSL Behring LLC Plasma-derived Therapies Revenue in Global (2016-2021)
        7.1.5 CSL Behring LLC Key News
    7.2 Shire
        7.2.1 Shire Corporate Summary
        7.2.2 Shire Business Overview
        7.2.3 Shire Plasma-derived Therapies Major Product Offerings
        7.2.4 Shire Plasma-derived Therapies Revenue in Global (2016-2021)
        7.2.5 Shire Key News
    7.3 Bayer
        7.3.1 Bayer Corporate Summary
        7.3.2 Bayer Business Overview
        7.3.3 Bayer Plasma-derived Therapies Major Product Offerings
        7.3.4 Bayer Plasma-derived Therapies Revenue in Global (2016-2021)
        7.3.5 Bayer Key News
    7.4 Kedrion
        7.4.1 Kedrion Corporate Summary
        7.4.2 Kedrion Business Overview
        7.4.3 Kedrion Plasma-derived Therapies Major Product Offerings
        7.4.4 Kedrion Plasma-derived Therapies Revenue in Global (2016-2021)
        7.4.5 Kedrion Key News
    7.5 Takeda
        7.5.1 Takeda Corporate Summary
        7.5.2 Takeda Business Overview
        7.5.3 Takeda Plasma-derived Therapies Major Product Offerings
        7.5.4 Takeda Plasma-derived Therapies Revenue in Global (2016-2021)
        7.5.5 Takeda Key News
    7.6 Biotest
        7.6.1 Biotest Corporate Summary
        7.6.2 Biotest Business Overview
        7.6.3 Biotest Plasma-derived Therapies Major Product Offerings
        7.6.4 Biotest Plasma-derived Therapies Revenue in Global (2016-2021)
        7.6.5 Biotest Key News
    7.7 Octaparma
        7.7.1 Octaparma Corporate Summary
        7.7.2 Octaparma Business Overview
        7.7.3 Octaparma Plasma-derived Therapies Major Product Offerings
        7.4.4 Octaparma Plasma-derived Therapies Revenue in Global (2016-2021)
        7.7.5 Octaparma Key News
    7.8 Bio Products Laboratory (BPL)
        7.8.1 Bio Products Laboratory (BPL) Corporate Summary
        7.8.2 Bio Products Laboratory (BPL) Business Overview
        7.8.3 Bio Products Laboratory (BPL) Plasma-derived Therapies Major Product Offerings
        7.8.4 Bio Products Laboratory (BPL) Plasma-derived Therapies Revenue in Global (2016-2021)
        7.8.5 Bio Products Laboratory (BPL) Key News
    7.9 LFB
        7.9.1 LFB Corporate Summary
        7.9.2 LFB Business Overview
        7.9.3 LFB Plasma-derived Therapies Major Product Offerings
        7.9.4 LFB Plasma-derived Therapies Revenue in Global (2016-2021)
        7.9.5 LFB Key News
    7.10 Grifols
        7.10.1 Grifols Corporate Summary
        7.10.2 Grifols Business Overview
        7.10.3 Grifols Plasma-derived Therapies Major Product Offerings
        7.10.4 Grifols Plasma-derived Therapies Revenue in Global (2016-2021)
        7.10.5 Grifols Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer


List of Tables and Figures
Ask Sample Report to get more details…

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com